DePinho's STAT3 company Tvardi raises $9M series A

Tvardi Therapeutics Inc. (Houston, Texas) raised $9 million in a series A round from Alexandria Venture Investments and other undisclosed institutional and private investors.

Tvardi is developing inhibitors of signal transducer and activator of transcription 3 (STAT3) to treat cancer and inflammatory and fibrotic diseases...